Nueno Carlos's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 3, 2026
- Accession no.
- 0002037711-26-000002
- Filed
- Mar 3, 2026
- Trade date
- Feb 27-Mar 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 5 derivative transactions. Open-market sales total $103.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nueno CarlosCIK 0002037711 | Officer (President, International) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +3,101 | – | – | 30,276 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +4,556 | – | – | 34,832 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +34,867 | – | – | 69,699 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +1,061 | – | – | 70,760 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −20,165 | $5.12 | −$103,244.8 | 50,595 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −3,101 | $0.00 | $0 | 0 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −4,556 | $0.00 | $0 | 18,226 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −34,867 | $0.00 | $0 | 69,735 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −1,061 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2026 | Common Stock | AGrant or awardAcquired | +173,010 | $0.00 | $0 | 173,010 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.